comparison of the effects of combination of two drugs used for giving spinal anesthesia for surgeries below the umbilicus.
Phase 4
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2023/04/051732
- Lead Sponsor
- Dr Shruti Desai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA grade I and II
BMI < 30 kg/m2
Patients who have given written informed consent.
Patients undergoing elective infraumbilical surgeries under spinal anaesthesia
Exclusion Criteria
1.ASA grade III and IV
2.Patients with known psychiatric illness, chronic pain or any condition that precludes intrathecal anesthesia.
3.Patients with deformity of the spine.
4.Patients with skin infection at the site of anesthesia.
5.Known sensitivity or allergy to the study drugs
6.Patients on chronic anticoagulants or antit platelet drugs or patients with coagulopathy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the onset and duration of sensory and motor blockade and duration of postoperative analgesiaTimepoint: The effects will be assessed at baseline,5,10,15, 20,25,30,60,90,120,150,180 minutes after giving spinal anesthesia.Postoperatively the analgesia effect will be assessed at baseline, 1,2,3,4,5,6,12 and 24 hours postoperatively.
- Secondary Outcome Measures
Name Time Method to assess perioperative hemodynamic stability and incidence of side effectsTimepoint: The hemodynamic stobility and adverse effects will be assessed intraoperatively at baseline,5,10,15, 20,25,30,60,90,120,150,180 minutes after giving spinal anesthesia. And Postoperatively it will be assessed at baseline, 1,2,3,4,5,6,12 and 24 hours postoperatively.